Table 1.
Experiment design and the dose of chromium malate, chromium trichloride and chromium picolinate
| Group | Rats | Dose (Cr, μg/kg bw) |
|---|---|---|
| Normal control group | Normal rats | – |
| Model group | Type 2 diabetic rats | – |
| Chromium trichloride-treated group | Type 2 diabetic rats | 20.8 |
| Chromium picolinate-treated group | Type 2 diabetic rats | 20.8 |
| Chromium malate-treated group 1 | Type 2 diabetic rats | 2.5 |
| Chromium malate-treated group 2 | Type 2 diabetic rats | 5.0 |
| Chromium malate-treated group 3 | Type 2 diabetic rats | 7.5 |
| Chromium malate-treated group 4 | Type 2 diabetic rats | 10.0 |
| Chromium malate-treated group 5 | Type 2 diabetic rats | 12.5 |
| Chromium malate-treated group 6 | Type 2 diabetic rats | 15.0 |
| Chromium malate-treated group 7 | Type 2 diabetic rats | 17.5 |
| Chromium malate-treated group 8 | Type 2 diabetic rats | 20.0 |
| Chromium malate-treated group 9 | Type 2 diabetic rats | 20.8 |
| Chromium malate control group | Normal rats | 20.8 |
BW, bodyweight
Cr, chromium.